The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: A systematic review of literature

Oncologist

Volumn 16, Issue 3, 2011, Pages 366-377

  van de Water, Tara A ^a   Bijl, Hendrik P ^a   Schilstra, Cornelis ^a   Pijls Johannesma, Madelon ^b   Langendijk, Johannes A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Head and neck cancer; In silico treatment planning; Proton therapy; Radiation induced side effects; Radiotherapy

Indexed keywords

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER MODEL; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LARYNX CANCER; NASOPHARYNX CANCER; OROPHARYNX CANCER; PARANASAL SINUS CANCER; PHOTON THERAPY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; SALIVARY GLAND DISEASE; SYSTEMATIC REVIEW; TREATMENT PLANNING; XEROSTOMIA;

FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PROTONS; RADIATION ONCOLOGY;

EID: 79952999153     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0171     Document Type: Article

References (39)

1. Machtay M, Moughan J, Trotti A et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol 2008;26:3582-3589.
2. Vergeer MR, Doornaert PA, Rietveld DH et al. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: Results of a nonrandomized prospective study using a standardized follow- up program. Int J Radiat Oncol Biol Phys 2009;74:1-8.
3. Schulz-Ertner D. The clinical experience with particle therapy in adults. Cancer J 2009;15:306-311.
4. Brada M, Pijls-Johannesma M, De Ruysscher D. Current clinical evidence for proton therapy. Cancer J 2009;15:319-324.
5. Laramore GE. Role of particle radiotherapy in the management of head and neck cancer. Curr Opin Oncol 2009;21:224-231.
6. Chan AW, Liebsch NJ. Proton radiation therapy for head and neck cancer. J Surg Oncol 2008;97:697-700.
7. Goitein M, Lomax AJ, Pedroni ES. Treating cancer with protons. Phys Today 2002;55:45-50.
8. Miralbell R, Crowell C, Suit HD. Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int J Radiat Oncol Biol Phys 1992;22:305-310.
9. Mock U, Georg D, Bogner J et al. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004;58:147-154.
10. Chera BS, Malyapa R, Louis D et al. Proton therapy for maxillary sinus carcinoma. Am J Clin Oncol 2009;32:296-303.
11. Lomax AJ, Goitein M, Adams J. Intensity modulation in radiotherapy: Photons versus protons in the paranasal sinus. Radiother Oncol 2003;66:11-18.
12. Brown AP, Urie MM, Chisin R et al. Proton therapy for carcinoma of the nasopharynx: A study in comparative treatment planning. Int J Radiat Oncol Biol Phys 1989;16:1607-1614.
13. Taheri-Kadkhoda Z, Björk-Eriksson T, Nill S et al. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: A comparative treatment planning study of photons and protons. Radiat Oncol 2008;3:4.
14. Widesott L, Pierelli A, Fiorino C et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: Planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008;72:589-596.
15. Slater JM, Slater JD, Archambeau JO. Carcinoma of the tonsillar region: Potential for use of proton beam therapy. Int J Radiat Oncol Biol Phys 1992; 22:311-319.
16. Cozzi L, Fogliata A, LomaxAet al.Atreatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001; 61:287-297.
17. Johansson J, Blomquist E, Montelius A et al. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol 2004;72:129-138.
18. Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 2006;80:263-267.
19. Muzik J, Soukup M, Alber M. Comparison of fixed-beam IMRT, helical tomotherapy, and IMPT for selected cases. Med Phys 2008;35:1580-1592.
20. Thorwarth D, Soukup M, Alber M. Dose painting with IMPT, helical tomotherapy and IMXT: A dosimetric comparison. Radiother Oncol 2008; 86:30-34.
21. Flynn RT, Bowen SR, Bentzen SM et al. Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. Phys Med Biol 2008;53:4153-4167.
22. Schilstra C, Meertens H. Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland. Int J Radiat Oncol Biol Phys 2001;50:147-158.
23. Ågren Cronquist A. Quantification of the Response of Heterogeneous Tumours and Organized Normal Tissues to Fractionated Radiotherapy. Doctoral Thesis. Stockholm, Sweden: Stockholm University, 1995:1-126.
24. Eisbruch A, Ten Haken RK, Kim HM et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensitymodulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-587.
25. Roesink JM, Moerland MA, Hoekstra A et al. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: A prospective study of dose-volume response relationships. Int J Radiat Oncol Biol Phys 2004;58:1451-1460.
26. Emami B, Lyman J, Brown A et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-122.
27. Burman C, Kutcher GJ, Emami B et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123-135.
28. Rancati T, Sanguineti G, Fiorino C. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination: Evidence of a large volume effect. Radiother Oncol 2007;84:S158-S159.
29. International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Photon Beam Therapy. ICRU Report 50. Bethesda, MD: ICRU, 1993:1-72.
30. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM et al. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008;26:3770-3776.
31. Dirix P, Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncol 2010;11:85-91.
32. Cozzia L, Bolsi A, Nicolinia G et al. The simultaneous integrated boost with proton beams in head and neck patients. Z Med Physik 2004;14:180-188.
33. Lomax AJ. Charged particle therapy: The physics of interaction. Cancer J 2009;15:285-291.
34. Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: The potential effects of calculational uncertainties. Phys Med Biol 2008;53:1027-1042.
35. Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008;53:1043-1056.
36. Goitein M, Jermann M. The relative costs of proton and X-ray radiation therapy. Clin Oncol (R Coll Radiol) 2003;15:S37-S50.
37. Peeters A, Grutters JP, Pijls-Johannesma M et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol 2010;95:45-53.
38. Miralbell R, Lomax A, Cella L et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002;54:824-829.
39. Lee CT, Bilton SD, Famiglietti RM et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: How do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 2005;63:362-372.